Know Cancer

or
forgot password

Long Term Outcomes in Critically Ill Haematological Patients. The Use of Intensive Care in Critically Ill Cancer Haematological Patients


N/A
18 Years
N/A
Not Enrolling
Both
Hematological Malignancies

Thank you

Trial Information

Long Term Outcomes in Critically Ill Haematological Patients. The Use of Intensive Care in Critically Ill Cancer Haematological Patients


1. To identify prognostic factors of short and medium term mortality, by underlining the
respective weights of organ dysfunction and characteristics of underlined malignancy

2. Evaluate the health related quality of life of intensive care survivors(SF36)

3. Impact of intensive care on families burden (HADS, IES).

4. Assess clinicians' satisfaction ( intensivists, haematologists and intensive care
nurses) in relation to medical decision-making.

5. Establish the relevance of antifungal treatments.


Inclusion Criteria:



- Hematological malignancies

- hospitalization in ICU

- age >= 18 years

Exclusion Criteria:

- Patients who have already participated to TRIAL-OH

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Survival status at one year

Outcome Description:

survival status (alive or death) at one year

Outcome Time Frame:

1 year

Safety Issue:

No

Principal Investigator

Elie Azoulay, MD, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Saint-Louis Hospital, Paris, France

Authority:

France: Ministry of Health

Study ID:

AOM 08235

NCT ID:

NCT01172132

Start Date:

November 2009

Completion Date:

November 2011

Related Keywords:

  • Hematological Malignancies
  • Leukemia
  • Lymphoma
  • Bone-Marrow Transplant
  • Neutropenia
  • Acute respiratory failure
  • Mechanical ventilation
  • Post ICU burden
  • ICU triage
  • Dialysis
  • Septic shock
  • Neoplasms
  • Critical Illness
  • Hematologic Neoplasms

Name

Location